Morgan Stanley Sees Strong Growth Potential for Cerner
In a report published Wednesday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Equal-Weight rating on Cerner (NASDAQ: CERN).
In the report, Morgan Stanley noted, “4Q13 bookings of $1.11B exceeded guidance of $1-$1.1B, up 9% y/y and 19% seq. Ex-marquee Intermountain deal ($100-$135M), would imply range of -4% to -1% y/y and 5%-9% seq. However, 1Q14 bookings guidance of $860-$930M implies strong 7-16% y/y growth, while seq decline of -22% to -16% is above recent historical trends of -21% in 1Q13 and -27% in 1Q12.”
Cerner Corporation closed on Tuesday at $56.60.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.